Q2 FY27 results: revenue down YoY, profits broadly stable
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 4.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved unaudited standalone results for Q2 and H1 FY27 (ended Sep 30, 2026). Q2 revenue from operations fell to Rs 1,066.21 lacs from Rs 1,243.63 lacs YoY. H1 PAT edged up to Rs 56.81 lacs from Rs 54.34 lacs. Total expenses eased in line with revenue. No dividend recommended. Auditor Shweta Jain and Co LLP issued an unmodified limited review report.
Revenue declined around 14 percent YoY in Q2 but profits stayed roughly flat. Clean audit and no dividend. Limited fresh trigger.